This study aimed to investigate in vivo dynamic metabolic changes after transplantation of
induced pluripotent stem cells (iPSCs) and iPSC-derived enriched cardiomyocytes (iPSC …

The purpose of this study was to determine the functionality of the transplanted induced
pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) in a rat model of cerebral …

Background Somatic stem cell (SC) therapy can improve cardiac performance following
ischemic injury. In this study, we investigated whether induced pluripotent SC-derived …

Background—Human induced pluripotent stem cells (iPSCs) are attractive candidates for
therapeutic use, with the potential to replace deficient cells and to improve functional …

Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) represent an attractive
resource for cardiac regeneration. However, survival and functional integration of …

Myocardial stem cell therapy in heart failure is strongly dependent on successful cellular
transfer, engraftment, and survival. Moreover, massive cell loss directly after intramyocardial …

Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC‐CMs) have the
potential to be a therapeutic option for myocardium restoration. However, hiPSC‐CMs of …

Background Human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have
shed great light on cardiac regenerative medicine and specifically myocardial repair in heart …

BACKGROUND: Remuscularization of the mammalian heart can be achieved after cell
transplantation of human induced pluripotent stem cell (hiPSC)–derived cardiomyocytes …

Background Cellular replacement strategies using human induced pluripotent stem cells
(iPSCs) and their cardiac derivatives are emerging as novel treatments for post-myocardial …